Versor Investments LP Dexcom Inc Transaction History

Versor Investments LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $70,371 - $97,389	-748 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$129.87 - $162.82 $97,142 - $121,789	748 New	748 $402,000
Q1 2019 May 09, 2019	SELL	$28.07 - $38.18 $134,736 - $183,264	-4,800 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $129,551 - $179,376	4,800 New	4,800 $575,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.